← Back to Patent Explorer
US5092838A Expired / Lapsed US ⏱️ 0.0 years remaining

Histidine buffered peritoneal dialysis solution

Assignee: Baxter International Inc
•
Filing: 1989-11-30
•
Granted: 1992-03-03
•
Expires: 2009-11-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A peritoneal dialysis solution buffered with L-histidine to a pH of at least 6.5. An apparatus and method for utilizing the solution is also disclosed.

Inventors

  • 👤 Dirk Faict
  • 👤 Francesco Peluso
  • 👤 Patrick Balteau

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 02:46
CPC Classifications
A; A61; A61M; A61M1/00; A61M1/14; A61M1/16; A61M1/28; A61M1/287; A61P; A61P7/00; A61P7/08

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 136 words
A method of performing peritoneal dialysis comprising: providing a first container of solution having a pH of less than 6; providing a second container of solution including an amino acid buffer being chosen from the group consisting essentially of histidine, its isomers, polymers and derivatives in a concentration such that after mixing said solutions, the final pH of the mixed solution will be greater than 6.5; providing fluid connection means connecting said first and second containers, said connection means being initially sealed to keep said solutions initially separate, said connections means being unsealable to allow mixing of said solutions; providing means for delivering the mixture of said solutions to a patient to perform peritoneal dialysis; unsealing said connections means to open said fluid connection; mixing said solutions; and delivering said mixed solution via said delivery means.
Claim 2
Independent Claim 136 words
A method of performing peritoneal dialysis comprising: providing a first container of solution having a pH of less than 6; providing a second container of solution including an amino acid buffer being chosen from the group consisting essentially of histidine, its isomers, polymers and derivatives in a concentration such that after mixing said solutions, the final pH of the mixed solution will be greater than 6.5; providing fluid connection means connecting said first and second containers, said connection means being initially sealed to keep said solutions initially separate, said connections means being unsealable to allow mixing of said solutions; providing means for delivering the mixture of said solutions to a patient to perform peritoneal dialysis; unsealing said connections means to open said fluid connection; mixing said solutions; and delivering said mixed solution via said delivery means.
Claim 3
Dependent Claim 25 words
The method of claim 1 wherein the amino acid concentration of said mixed solution is in the range of 0.01 to 60 millimoles per liter.
Claim 4
Dependent Claim 25 words
The method of claim 2 wherein the amino acid concentration of said mixed solution is in the range of 1 to 20 millimoles per liter.
Claim 5
Dependent Claim 12 words
The method of claim 1 wherein said amino acid buffer is L-histidine.
Claim 6
Dependent Claim 35 words
A peritoneal dialysis solution buffered with at least one amino acid to a pH of at least 6.5, said amino acid being chosen from the group consisting essentially of histidine, its isomers, polymers and derivatives.
Claim 7
Dependent Claim 35 words
A peritoneal dialysis solution buffered with at least one amino acid to a pH of at least 6.5, said amino acid being chosen from the group consisting essentially of histidine, its isomers, polymers and derivatives.
Claim 8
Dependent Claim 13 words
The peritoneal dialysis solution of claim 5 wherein said amino acid is L-histidine.
Claim 9
Dependent Claim 20 words
The peritoneal dialysis solution of claim 6 wherein said solution comprises 0.01 to 60 millimoles per liter of said L-histidine.
Claim 10
Dependent Claim 21 words
The peritoneal dialysis solution of claim 7 wherein said solution comprises between 1 to 20 millimoles per liter of said L-histidine.
Claim 11
Dependent Claim 21 words
The peritoneal dialysis solution of claim 5 wherein said solution comprises 0.01 to 60 millimoles per liter of said amino acid.
Claim 12
Dependent Claim 22 words
The peritoneal dialysis solution of claim 9 wherein said solution comprises between 1 to 20 millimoles per liter of said amino acid.

References Cited (Backward Citations)

US3764703A Cited
US4761237A Cited
US4976683A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-03-03 1995-09-02 1996-03-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-03-03 1999-09-02 2000-03-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-03-03 2003-09-02 2004-03-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag